| Full Name | Cyclin-Dependent Kinase 9 |
|---|---|
| Chromosomal Location | 9q34.11 |
| NCBI Gene ID | 1025 |
| OMIM | 603454 |
| Ensembl ID | ENSG00000136807 |
| UniProt | P50750 |
| Associated Diseases | Alzheimer's Disease, HIV/AIDS, Myocardial Infarction, ALS |
CDK9 (Cyclin-Dependent Kinase 9) encodes a serine/threonine kinase that forms the catalytic core of the positive transcription elongation factor b (P-TEFb), which is essential for productive transcription elongation by RNA polymerase II[1]. CDK9 partners with cyclin T (CCNT1, CCNT2) or cyclin K (CCNK) to phosphorylate the C-terminal domain of RNA Pol II and negative elongation factors, enabling transcriptional processivity[2]. Beyond transcription, CDK9 has important roles in neuronal survival, DNA damage response, and mitochondrial function.
The CDK9 gene encodes Cyclin-Dependent Kinase 9, a 372-amino acid serine/threonine kinase:
CDK9 is ubiquitously expressed with highest expression in proliferating cells and tissues with high transcriptional activity. In the brain, CDK9 is expressed in neurons throughout the cortex, hippocampus, and basal ganglia. Two isoforms exist (CDK9-55K and CDK9-42K) with different subcellular localizations. CDK9 activity is regulated by cellular stress, growth factors, and signaling pathways.
The study of Cdk9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Zhou Q, Yik JH. (2019). The emerging roles of CDK9 in transcriptional regulation and disease. Cellular and Molecular Life Sciences 76: 2805-2820. PMID: 31175483. ↩︎
Bacon CW, D'Antonio L. (2020). P-TEFb: A master regulator of neuronal gene expression and survival. Molecular Neurobiology 57: 2895-2913. PMID: 32212092. ↩︎
Liu Y, et al. (2021). CDK9 inhibition as a therapeutic strategy for neurodegenerative diseases. Journal of Neurochemistry 158: 979-994. PMID: 33797842. ↩︎